Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice.

Ziv Y, Rahamim N, Lezmy N, Even-Chen O, Shaham O, Malishkevich A, Giladi E, Elkon R, Gozes I, Barak S.

Neuropsychopharmacology. 2018 Jun 27. doi: 10.1038/s41386-018-0132-7. [Epub ahead of print]

PMID:
30008470
2.

Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis.

Escher U, Giladi E, Dunay IR, Bereswill S, Gozes I, Heimesaat MM.

Eur J Microbiol Immunol (Bp). 2018 May 23;8(2):34-40. doi: 10.1556/1886.2018.00006. eCollection 2018 Jun 25.

3.

The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis.

Heimesaat MM, Giladi E, Kühl AA, Bereswill S, Gozes I.

Peptides. 2018 Mar;101:1-9. doi: 10.1016/j.peptides.2017.12.023. Epub 2017 Dec 27.

4.

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.

Scally SW, McLeod B, Bosch A, Miura K, Liang Q, Carroll S, Reponen S, Nguyen N, Giladi E, Rämisch S, Yusibov V, Bradley A, Lemiale F, Schief WR, Emerling D, Kellam P, King CR, Julien JP.

Nat Commun. 2017 Nov 16;8(1):1568. doi: 10.1038/s41467-017-01924-3.

5.

Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.

DeFalco J, Harbell M, Manning-Bog A, Baia G, Scholz A, Millare B, Sumi M, Zhang D, Chu F, Dowd C, Zuno-Mitchell P, Kim D, Leung Y, Jiang S, Tang X, Williamson KS, Chen X, Carroll SM, Espiritu Santo G, Haaser N, Nguyen N, Giladi E, Minor D, Tan YC, Sokolove JB, Steinman L, Serafini TA, Cavet G, Greenberg NM, Glanville J, Volkmuth W, Emerling DE, Robinson WH.

Clin Immunol. 2018 Feb;187:37-45. doi: 10.1016/j.clim.2017.10.002. Epub 2017 Oct 12.

6.

Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children.

Gozes I, Van Dijck A, Hacohen-Kleiman G, Grigg I, Karmon G, Giladi E, Eger M, Gabet Y, Pasmanik-Chor M, Cappuyns E, Elpeleg O, Kooy RF, Bedrosian-Sermone S.

Transl Psychiatry. 2017 Jul 4;7(7):e1166. doi: 10.1038/tp.2017.128.

7.

Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children.

Gozes I, Van Dijck A, Hacohen-Kleiman G, Grigg I, Karmon G, Giladi E, Eger M, Gabet Y, Pasmanik-Chor M, Cappuyns E, Elpeleg O, Kooy RF, Bedrosian-Sermone S.

Transl Psychiatry. 2017 Feb 21;7(2):e1043. doi: 10.1038/tp.2017.27. Erratum in: Transl Psychiatry. 2017 Jul 4;7(7):e1166.

8.

Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.

Amram N, Hacohen-Kleiman G, Sragovich S, Malishkevich A, Katz J, Touloumi O, Lagoudaki R, Grigoriadis NC, Giladi E, Yeheskel A, Pasmanik-Chor M, Jouroukhin Y, Gozes I.

Mol Psychiatry. 2016 Oct;21(10):1467-76. doi: 10.1038/mp.2015.208. Epub 2016 Jan 19.

PMID:
26782054
9.

Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model.

Vaisburd S, Shemer Z, Yeheskel A, Giladi E, Gozes I.

Sci Rep. 2015 Nov 10;5:16300. doi: 10.1038/srep16300.

10.

Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.

Blume-Jensen P, Berman DM, Rimm DL, Shipitsin M, Putzi M, Nifong TP, Small C, Choudhury S, Capela T, Coupal L, Ernst C, Hurley A, Kaprelyants A, Chang H, Giladi E, Nardone J, Dunyak J, Loda M, Klein EA, Magi-Galluzzi C, Latour M, Epstein JI, Kantoff P, Saad F.

Clin Cancer Res. 2015 Jun 1;21(11):2591-600. doi: 10.1158/1078-0432.CCR-14-2603. Epub 2015 Mar 2.

11.

Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies.

Malishkevich A, Amram N, Hacohen-Kleiman G, Magen I, Giladi E, Gozes I.

Transl Psychiatry. 2015 Feb 3;5:e501. doi: 10.1038/tp.2014.138.

12.

New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Merenlender-Wagner A, Shemer Z, Touloumi O, Lagoudaki R, Giladi E, Andrieux A, Grigoriadis NC, Gozes I.

Autophagy. 2014;10(12):2324-32. doi: 10.4161/15548627.2014.984274.

13.

The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.

Oz S, Kapitansky O, Ivashco-Pachima Y, Malishkevich A, Giladi E, Skalka N, Rosin-Arbesfeld R, Mittelman L, Segev O, Hirsch JA, Gozes I.

Mol Psychiatry. 2014 Oct;19(10):1115-24. doi: 10.1038/mp.2014.97. Epub 2014 Sep 2.

PMID:
25178163
14.

Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality.

Shipitsin M, Small C, Giladi E, Siddiqui S, Choudhury S, Hussain S, Huang YE, Chang H, Rimm DL, Berman DM, Nifong TP, Blume-Jensen P.

Proteome Sci. 2014 Jul 12;12:40. doi: 10.1186/1477-5956-12-40. eCollection 2014.

15.

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.

Shipitsin M, Small C, Choudhury S, Giladi E, Friedlander S, Nardone J, Hussain S, Hurley AD, Ernst C, Huang YE, Chang H, Nifong TP, Rimm DL, Dunyak J, Loda M, Berman DM, Blume-Jensen P.

Br J Cancer. 2014 Sep 9;111(6):1201-12. doi: 10.1038/bjc.2014.396. Epub 2014 Jul 17.

16.

CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking.

Bar-Shira A, Gana-Weisz M, Gan-Or Z, Giladi E, Giladi N, Orr-Urtreger A.

Neurobiol Aging. 2014 Sep;35(9):2179.e1-6. doi: 10.1016/j.neurobiolaging.2014.03.014. Epub 2014 Mar 20.

PMID:
24731518
17.

Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).

Gozes I, Iram T, Maryanovsky E, Arviv C, Rozenberg L, Schirer Y, Giladi E, Furman-Assaf S.

J Alzheimers Dis. 2014;40 Suppl 1:S23-36. doi: 10.3233/JAD-131664.

PMID:
24503616
18.

Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation.

Schirer Y, Malishkevich A, Ophir Y, Lewis J, Giladi E, Gozes I.

PLoS One. 2014 Jan 29;9(1):e87383. doi: 10.1371/journal.pone.0087383. eCollection 2014.

19.

NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.

Jouroukhin Y, Ostritsky R, Assaf Y, Pelled G, Giladi E, Gozes I.

Neurobiol Dis. 2013 Aug;56:79-94. doi: 10.1016/j.nbd.2013.04.012. Epub 2013 Apr 28.

PMID:
23631872
20.

Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations.

Thompson JF, Reifenberger JG, Giladi E, Kerouac K, Gill J, Hansen E, Kahvejian A, Kapranov P, Knope T, Lipson D, Steinmann KE, Milos PM.

Genome Res. 2012 Feb;22(2):340-5. doi: 10.1101/gr.122192.111. Epub 2011 Jul 15.

21.

Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.

Shiryaev N, Pikman R, Giladi E, Gozes I.

Curr Pharm Des. 2011;17(25):2603-12. Review.

PMID:
21728979
22.

Error tolerant indexing and alignment of short reads with covering template families.

Giladi E, Healy J, Myers G, Hart C, Kapranov P, Lipson D, Roels S, Thayer E, Letovsky S.

J Comput Biol. 2010 Oct;17(10):1397-1411. doi: 10.1089/cmb.2010.0005.

PMID:
20937014
23.

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

Merenlender-Wagner A, Pikman R, Giladi E, Andrieux A, Gozes I.

Peptides. 2010 Jul;31(7):1368-73. doi: 10.1016/j.peptides.2010.04.011. Epub 2010 Apr 22.

PMID:
20417241
24.

The effects of vascular intrauterine growth retardation on cortical astrocytes.

Bassan H, Kidron D, Bassan M, Rotstein M, Kariv N, Giladi E, Davidson A, Gozes I, Harel S.

J Matern Fetal Neonatal Med. 2010 Jul;23(7):595-600. doi: 10.1080/14767050903197068.

PMID:
19757337
25.

PolyADP-ribosylation is required for long-term memory formation in mammals.

Goldberg S, Visochek L, Giladi E, Gozes I, Cohen-Armon M.

J Neurochem. 2009 Oct;111(1):72-9. doi: 10.1111/j.1471-4159.2009.06296.x. Epub 2009 Jul 23.

26.

Quantification of the yeast transcriptome by single-molecule sequencing.

Lipson D, Raz T, Kieu A, Jones DR, Giladi E, Thayer E, Thompson JF, Letovsky S, Milos P, Causey M.

Nat Biotechnol. 2009 Jul;27(7):652-8. doi: 10.1038/nbt.1551. Epub 2009 Jul 5.

PMID:
19581875
27.

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.

Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, Gozes I.

Neurobiol Dis. 2009 May;34(2):381-8. doi: 10.1016/j.nbd.2009.02.011. Epub 2009 Mar 2.

PMID:
19264130
28.

Single-molecule DNA sequencing of a viral genome.

Harris TD, Buzby PR, Babcock H, Beer E, Bowers J, Braslavsky I, Causey M, Colonell J, Dimeo J, Efcavitch JW, Giladi E, Gill J, Healy J, Jarosz M, Lapen D, Moulton K, Quake SR, Steinmann K, Thayer E, Tyurina A, Ward R, Weiss H, Xie Z.

Science. 2008 Apr 4;320(5872):106-9. doi: 10.1126/science.1150427.

29.

Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Giladi E, Hill JM, Dresner E, Stack CM, Gozes I.

J Mol Neurosci. 2007;33(3):278-83. Epub 2007 Oct 2.

PMID:
17952637
30.

The pregnant spontaneously hypertensive rat as a model of asymmetric intrauterine growth retardation and neurodevelopmental delay.

Bassan H, Bassan M, Pinhasov A, Kariv N, Giladi E, Gozes I, Harel S.

Hypertens Pregnancy. 2005;24(3):201-11.

PMID:
16263593
31.

Neuropeptide receptor transcripts are expressed in the rat clitoris and oscillate during the estrus cycle in the rat vagina.

Dangoor D, Giladi E, Fridkin M, Gozes I.

Peptides. 2005 Dec;26(12):2579-84. Epub 2005 Jul 14.

PMID:
16023261
32.
33.

The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide.

Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, Gozes I.

Peptides. 2003 Sep;24(9):1413-23.

PMID:
14706557
34.

Activity-dependent neuroprotective protein: a novel gene essential for brain formation.

Pinhasov A, Mandel S, Torchinsky A, Giladi E, Pittel Z, Goldsweig AM, Servoss SJ, Brenneman DE, Gozes I.

Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90.

PMID:
12888219
35.

Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults.

Zaltzman R, Beni SM, Giladi E, Pinhasov A, Steingart RA, Romano J, Shohami E, Gozes I.

Neuroreport. 2003 Mar 3;14(3):481-4.

PMID:
12634508
37.

NAP accelerates the performance of normal rats in the water maze.

Gozes I, Alcalay R, Giladi E, Pinhasov A, Furman S, Brenneman DE.

J Mol Neurosci. 2002 Aug-Oct;19(1-2):167-70.

PMID:
12212775
38.

SST: an algorithm for finding near-exact sequence matches in time proportional to the logarithm of the database size.

Giladi E, Walker MG, Wang JZ, Volkmuth W.

Bioinformatics. 2002 Jun;18(6):873-7.

PMID:
12075023
39.

NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death.

Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M, Giladi E, Romano J, Gozes I.

Stroke. 2002 Apr;33(4):1085-92.

40.

Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures.

Ashur-Fabian O, Giladi E, Furman S, Steingart RA, Wollman Y, Fridkin M, Brenneman DE, Gozes I.

Neurosci Lett. 2001 Jul 20;307(3):167-70.

PMID:
11438390
41.

A novel VIP responsive gene. Activity dependent neuroprotective protein.

Gozes I, Zamostiano R, Pinhasov A, Bassan M, Giladi E, Steingart RA, Brenneman DE.

Ann N Y Acad Sci. 2000;921:115-8.

PMID:
11193814
42.

Cloning and characterization of the human activity-dependent neuroprotective protein.

Zamostiano R, Pinhasov A, Gelber E, Steingart RA, Seroussi E, Giladi E, Bassan M, Wollman Y, Eyre HJ, Mulley JC, Brenneman DE, Gozes I.

J Biol Chem. 2001 Jan 5;276(1):708-14.

43.

Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.

Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE.

J Pharmacol Exp Ther. 2000 Jun;293(3):1091-8.

44.

A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein.

Gozes I, Bassan M, Zamostiano R, Pinhasov A, Davidson A, Giladi E, Perl O, Glazner GW, Brenneman DE.

Ann N Y Acad Sci. 1999;897:125-35. Review.

PMID:
10676441
45.

Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

Gozes I, Perl O, Giladi E, Davidson A, Ashur-Fabian O, Rubinraut S, Fridkin M.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4143-8.

46.

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.

Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, Brenneman DE, Gozes I.

J Neurochem. 1999 Mar;72(3):1283-93.

47.

The identification of secreted heat shock 60 -like protein from rat glial cells and a human neuroblastoma cell line.

Bassan M, Zamostiano R, Giladi E, Davidson A, Wollman Y, Pitman J, Hauser J, Brenneman DE, Gozes I.

Neurosci Lett. 1998 Jun 26;250(1):37-40.

PMID:
9696060
48.

Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides.

Ashur-Fabian O, Giladi E, Brenneman DE, Gozes I.

J Mol Neurosci. 1997 Dec;9(3):211-22.

PMID:
9481622
49.
50.

Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease.

Gozes I, Bachar M, Bardea A, Davidson A, Rubinraut S, Fridkin M, Giladi E.

J Neurobiol. 1997 Sep;33(3):329-42.

PMID:
9298769

Supplemental Content

Loading ...
Support Center